Shares of GSK PLC GSK inched down 0.51% to £13.57 Friday, on what proved to be an all-around poor trading session for the ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

Ken Hall looks at three important considerations for investors looking to build a sizeable passive income for a better financial future.

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Before this role, Saurabh worked at Godrej Consumer Products, where he most recently served as the category head of marketing for home care.

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

Rising homeowner’s insurance costs could disrupt some financial plans in the coming years. Last year was the second ...

The rise in Netflix stock price doesn’t mean the opportunity for investors is over, a Bernstein analyst argued on Friday.

Jefferies analyst Peter Welford maintained a Sell rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK515.00.

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop.